{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:07:05Z","timestamp":1791173225609,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.actatropica.2015.07.013","type":"journal-article","created":{"date-parts":[[2015,7,19]],"date-time":"2015-07-19T10:04:20Z","timestamp":1437300260000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection"],"prefix":"10.1016","volume":"150","author":[{"given":"Vanesa R.","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio M.","family":"Fenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano S.","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna S.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Arcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2015.07.013_bib0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0966-842X(03)00205-1","article-title":"Migration of Toxoplasma gondii across biological barriers","volume":"11","author":"Barragan","year":"2003","journal-title":"Trends Microbiol."},{"issue":"Suppl. 3","key":"10.1016\/j.actatropica.2015.07.013_bib0010","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum salts in vaccines\u2014US perspective","volume":"20","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0015","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1017\/S003118200000144X","article-title":"A commercial vaccine for ovine toxoplasmosis","volume":"110","author":"Buxton","year":"1995","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1462-5822.2006.00692.x","article-title":"Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections","volume":"8","author":"Buzoni-Gatel","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/hum.2006.17.415","article-title":"Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice","volume":"17","author":"Caetano","year":"2006","journal-title":"Human Gene Ther."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/neuonc\/nop047","article-title":"Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study","volume":"12","author":"Carpentier","year":"2010","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmj.321.7254.142","article-title":"Sources of toxoplasma infection in pregnant women: European multicentre case-control studyCommentary: congenital toxoplasmosis\u2014further thought for food","volume":"321","author":"Cook","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0020-7519(01)00354-X","article-title":"Recent advances in the search for new anti-coccidial drugs","volume":"32","author":"Coombs","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2005-02-0666","article-title":"CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain","volume":"107","author":"Courret","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0050","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1016\/j.vaccine.2008.07.031","article-title":"Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis","volume":"26","author":"Cuppari","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0055","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/IAI.64.6.2158-2166.1996","article-title":"Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection","volume":"64","author":"Debard","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0060","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/pbi.12001","article-title":"A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice","volume":"10","author":"del","year":"2012","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1590\/S0074-02762009000200011","article-title":"Population biology of Toxoplasma gondii: what\u2019s out and where did they come from","volume":"104","author":"Dubey","year":"2009","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0070","doi-asserted-by":"crossref","first-page":"e8787","DOI":"10.1371\/journal.pone.0008787","article-title":"Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1\/Alhydrogel with and without CPG 7909 in Malaria Na\u00efve Adults","volume":"5","author":"Ellis","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0075","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/IAI.00622-10","article-title":"CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to chlamydia muridarum genital infection","volume":"78","author":"Farris","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0080","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2007.02.057","article-title":"Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice","volume":"25","author":"Golkar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0085","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.vaccine.2009.01.100","article-title":"Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant","volume":"27","author":"Hedhli","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0090","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.4049\/jimmunol.177.12.8785","article-title":"Gram-negative bacteria aggravate murine small intestinal Th1-Type immunopathology following oral infection with Toxoplasma gondii","volume":"177","author":"Heimesaat","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0095","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.exppara.2007.10.002","article-title":"Toxoplasma gondii: Evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB\/c mice","volume":"118","author":"Igarashi","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0105","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.4049\/jimmunol.0900640","article-title":"Early response of mucosal epithelial cells during Toxoplasma gondii infection","volume":"183","author":"Ju","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijpara.2003.11.023","article-title":"Toxoplasma gondii and mucosal immunity","volume":"34","author":"Kasper","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0115","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/eji.200324696","article-title":"CD4\u2013c-kit\u2013CD3\u03f5\u2013IL-2R\u03b1+ Peyer\u2019s patch cells are a novel cell subset which secrete IL-5 in response to IL-2: implications for their role in IgA production","volume":"34","author":"Kuraoka","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1472-6750-10-52","article-title":"Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice","volume":"10","author":"Laguia-Becher","year":"2010","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3347\/kjp.2014.52.6.581","article-title":"Recent advances in immunotherapeutics","volume":"52","author":"Lim","year":"2014","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0130","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0135","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s00436-014-3882-0","article-title":"Vaccination with Toxoplasma lysate antigen and CpG oligodeoxynucleotides: comparison of immune responses in intranasal versus intramuscular administrations","volume":"113","author":"MA","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0140","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CDLI.11.4.704-710.2004","article-title":"Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis","volume":"11","author":"Martin","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0145","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.vaccine.2010.02.003","article-title":"Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity","volume":"28","author":"Machado","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0150","doi-asserted-by":"crossref","first-page":"e63201","DOI":"10.1371\/journal.pone.0063201","article-title":"Recombinant vaccines against T. gondii: Comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1","volume":"8","author":"Mendes","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0155","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/1471-2334-13-494","article-title":"DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB\/c mice","volume":"13","author":"Meng","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0160","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0165","doi-asserted-by":"crossref","first-page":"45259","DOI":"10.1074\/jbc.M205517200","article-title":"Functional analysis of Toxoplasma gondii protease inhibitor 1","volume":"277","author":"Morris","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.actatropica.2015.07.013_bib0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nri2097","article-title":"T(H) 1 cells control themselves by producing interleukin-10","volume":"7","author":"O\u2019Garra","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0166-6851(00)00202-4","article-title":"Molecular cloning, sequencing and expressing of a serine proteinase inhibitor gene from Toxoplasma gondii","volume":"107","author":"Pszenny","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0166-6851(02)00045-2","article-title":"Subcellular localization and post-secretory targeting of TgPI, a serine proteinase inhibitor from Toxoplasma gondii","volume":"121","author":"Pszenny","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0185","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/erv.09.86","article-title":"Genetic heterologous prime\u2014boost vaccination strategies for improved systemic and mucosal immunity","volume":"8","author":"Ranasinghe","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0190","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.exppara.2011.04.004","article-title":"Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection","volume":"128","author":"S\u00e1nchez","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0195","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/j.vaccine.2009.03.013","article-title":"Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge","volume":"27","author":"Shang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0200","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/IAI.68.2.969-972.2000","article-title":"Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments","volume":"68","author":"Velge-Roussel","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0205","doi-asserted-by":"crossref","first-page":"e108377","DOI":"10.1371\/journal.pone.0108377","article-title":"Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2015.07.013_bib0210","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1073\/pnas.84.21.7388","article-title":"Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5","volume":"84","author":"Yokota","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.parint.2012.04.001","article-title":"Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice","volume":"61","author":"Yu","year":"2012","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.actatropica.2015.07.013_bib0220","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1017\/S0031182007002892","article-title":"A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice","volume":"134","author":"- Zhang","year":"2007","journal-title":"Parasitology"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T02:21:47Z","timestamp":1599272507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X15300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":44,"alternative-id":["S0001706X15300607"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.07.013","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}